EMA Launches Interactive Map for Clinical Trials Information

The European Medicines Agency (EMA) has unveiled an interactive map designed to provide vital information regarding clinical trials across the European Union. This tool enhances user access to data from the Clinical Trials Information System (CTIS), fostering greater participation in clinical research.

The interactive map, initially available in English, aims to facilitate easy access for patients and healthcare professionals to comprehensive and up-to-date information about ongoing clinical trials in their vicinity. The initiative is expected to stimulate involvement in clinical research within the EU.

Utilizing publicly available data from the CTIS, the map enhances the usability of the system and makes information about clinical trials more accessible. Users can view ongoing studies by country and conduct searches using layman's terms. Additionally, an autocorrect feature assists with spelling errors, providing suggestions to aid in accurate searching. The search results will also include details about participation opportunities in specific studies.

The CTIS offers a publicly searchable database aimed at medical professionals, patients, and citizens, ensuring a legally mandated increase in transparency. While the oversight and approval of clinical trials fall under the jurisdiction of the member states of the European Economic Area, the EMA is responsible for the CTIS.

This new map is part of a broader initiative to accelerate clinical trials within the EU, which the EMA introduced in 2023. The accompanying website was launched as part of this effort. The regulation governing clinical trials took effect in 2022, with the EU Commission overseeing its implementation. According to the Federal Institute for Drugs and Medical Devices (BfArM), this framework aims to unify the submission, assessment, and monitoring procedures for clinical trials across the EU through the Clinical Trials Information System.